-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NG-641 in Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. NG-641 in Colorectal Cancer Drug Details: NG-641 is under development for the treatment of metastatic...
-
Product Insights
NewNet Present Value Model: Trevi Therapeutics Inc’s Nalbuphine Hydrochloride ER
Empower your strategies with our Net Present Value Model: Trevi Therapeutics Inc's Nalbuphine Hydrochloride ER report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NG-641 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NG-641 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NG-641 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drug...
-
Company Profile
Trevi Therapeutics Inc – Company Profile
Trevi Therapeutics Inc (Trevi Therapeutics) is a clinical-stage biopharmaceutical company. It offers the product Haduvio which uses for the treatment of serious cough conditions including IPF, interstitial lung diseases, and refractory chronic cough. The company offers nalbuphine ER as its pipeline product. Its product is being developed for treating patients with prurigo nodularis, pruritus in chronic liver disease, chronic cough related to idiopathic pulmonary fibrosis (IPF) and levodopa-induced dyskinesia (LID). It operates across the US. Trevi Therapeutics is headquartered in...
Add to Basket -
Product Insights
Net Present Value Model: Nalbuphine Hydrochloride ER
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Nalbuphine Hydrochloride ER Drug Details Nalbuphine...
-
Product Insights
Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Dyskinesia refers to the involuntary nature of muscular movements or the difficulty in performing voluntary muscular movements. Its symptoms include facial grimacing, finger movement, jaw swinging, repetitive chewing, and tongue thrusting. However, the disease can be controlled by a healthy lifestyle and medication. The Dyskinesia pipeline market research report provides comprehensive information on the therapeutics under development for Dyskinesia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The...
-
Product Insights
Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cough can occur with many signs and symptoms which include stuffy nose, hoarseness, wheezing and shortness of breath, and heartburn or a sour taste in the mouth. The treatment for cough entails antihistamines, decongestants, antibiotics, and cough suppressants. The Cough pipeline market research report provides an overview of the Cough pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cough, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration...
-
Sector Analysis
Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is caused by cancer, cancer treatments, infection, dry skin and reaction to a drug. Symptoms include redness, bumps, spots or blisters, dry, cracked skin and leathery or scaly texture to the skin. Risk factors include heat, allergic, asthma, hay fever, hives and eczema. Treatment includes corticosteroids, antihistamines and antidepressants. The Pruritus- Drugs in Development research report provides a comprehensive overview on the therapeutics under...
-
Product Insights
Pruritus Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Pruritus Global Clinical Trials Review, H1, 2020" provides an overview of Pruritus Clinical trials scenario. This report provides top line data relating to the clinical trials on Pruritus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Uremic (Renal) Pruritus Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Uremic (Renal) Pruritus Global Clinical Trials Review, H2, 2018" provides an overview of Uremic (Renal) Pruritus clinical trials scenario. This report provides top line data relating to the clinical trials on Uremic (Renal) Pruritus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...